课题基金 / 基金详情

Multidisciplinary Approaches to Tumor Immunology

Multidisciplinary Approaches to Tumor Immunology
肿瘤免疫学的多学科方法
批准号:
10709095
负责人:
Scott I. Abrams
金额:
$14.41万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
未结题
起止时间:
2001-07-01 至 2028-08-31

项目摘要

项目成果

Scott I. Abrams的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT The overarching goals of the Tumor Immunology Training Program (TITP) at Roswell Park Comprehensive Cancer Center Graduate Division are to educate, train, and prepare talented pre-doctoral trainees for a profession in cancer immunology research. Driven by significant advances in understanding how the immune system can be weaponized against cancer, future leaders in tumor immunology will not only be well-trained in the discipline, but also will have a strong appreciation of the potential translational impact to human cancer biology and therapy. The unique, cancer-focus of the TITP introduces trainees to an advanced didactic and conceptual cancer immunology educational paradigm that encapsulates knowledge spanning the continuum of basic science to clinical application. The uniqueness of this TITP is further enhanced by the integration of an academic environment comprised of diverse faculty concentrated within a prestigious NCI-designated Comprehensive Cancer Center. Throughout the program, trainees are continually exposed to a comprehensive portfolio of themes and concepts in tumor immunology, responsible conduct of research, and the principles of rigor and reproducibility. Trainees conduct their doctoral research with TITP mentors with expertise in basic, translational, and clinical tumor immunology. The primary mission of the TITP is to support competitively selected trainees during their third and fourth years of study. The funds requested cover stipends and tuition for 4 pre-doctoral trainees per year. This funding is crucial to continue the upward trajectory experienced for nearly 20 years of NRSA support in the quality and diversity of pre-doctoral trainees focused on complex and challenging immunologic questions in cancer. NRSA-supported trainees are prepared for a competitive biomedical career through didactic lectures and concept-driven learning in tumor immunology and biology, grant writing, responsible conduct of research, and rigor and reproducibility. After trainees complete all formal course work and pass a qualifying exam, degree conferral is dependent upon fulfilling a first-authored publication requirement and passing the dissertation defense reflecting the novel and original findings of the trainee’s body-of-work. Trainees who complete this TITP will be well-versed in all major facets of tumor immunology and will have the solid foundation upon which to build cancer-focused careers, guided by a clear vision of its impact on human cancer biology and treatment.
期刊论文(36)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3109/02656736.2013.807440
发表时间: 2013-08
期刊: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
影响因子: --
作者: [Mikucki ME, Fisher DT, Ku AW, Appenheimer MM, Muhitch JB, Evans SS]
通讯作者: Evans SS
Regulation of the interferon regulatory factor-8 (IRF-8) tumor suppressor gene by the signal transducer and activator of transcription 5 (STAT5) transcription factor in chronic myeloid leukemia.
慢性粒细胞白血病中信号转导器和转录激活剂 5 (STAT5) 转录因子对干扰素调节因子 8 (IRF-8) 肿瘤抑制基因的调节。
DOI: 10.1074/jbc.m113.544320
发表时间: 2014
期刊: The Journal of biological chemistry
影响因子: --
作者: [Waight,JeremyD, Banik,Debarati, Griffiths,ElizabethA, Nemeth,MichaelJ, Abrams,ScottI]
通讯作者: Abrams,ScottI
DOI: 10.1371/journal.pone.0120327
发表时间: 2015
期刊: PloS one
影响因子: 3.7
作者: [Lee CT, Kokolus KM, Leigh ND, Capitano M, Hylander BL, Repasky EA]
通讯作者: Repasky EA
DOI: 10.3109/02656736.2014.981300
发表时间: 2014-12
期刊: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
影响因子: --
作者: [Eng JW, Reed CB, Kokolus KM, Repasky EA]
通讯作者: Repasky EA
27
    Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity
    Development of a Novel Immunotherapy Platform for Triple-Negative Breast Cancer
    Development of a Novel Immunotherapy Platform for Triple-Negative Breast Cancer
    Impact of Circulating Myeloid Cell Clusters on Anti-Tumor Immunity
    海外基金